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Summary
The mechanisms through which estrogen regulates
gonadotropin-releasing hormone (GnRH) neurons to
control mammalian ovulation are unknown. We found
that estrogen positive feedback to generate the pre-
ovulatory gonadotropin surge was normal in estrogen
receptor b knockout (ERb) mutant mice, but absent in
ERa mutant mice. An ERa-selective compound was
sufficient to generate positive feedback in wild-type
mice. As GnRH neurons do not express ERa, estrogen
positive feedback upon GnRH neurons must be indi-
rect in nature. To establish the cell type responsible,
we generated a neuron-specific ERa mutant mouse
line. Thesemice failed to exhibit estrogen positive feed-
back, demonstrating that neurons expressing ERa are
critical. We then used a GnRH neuron-specific Pseu-
dorabies virus (PRV) tracing approach to show that
the ERa-expressing neurons innervating GnRH neu-
rons are located within rostral periventricular regions
of the hypothalamus. These studies demonstrate that
ovulation is driven by estrogen actions upon ERa-
expressing neuronal afferents to GnRH neurons.
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The gonadotropin-releasing hormone (GnRH) neurons
represent the key output cells of the neuronal network
controlling fertility in all mammalian species. The
GnRH neurons and associated cells that comprise the
‘‘GnRH neuronal network’’ are responsible for integrat-
ing multiple internal homeostatic and external environ-
mental signals to ensure appropriate levels of fertility
for the individual (Levine, 1997; Herbison, 2006). Argu-
ably, the most important of these signals is that of
estrogen, secreted by the gonads to achieve feedback
regulation of gonadotropin secretion (Herbison, 1998;
Petersen et al., 2003). Throughout most of the menstrual
cycle, estrogen suppresses gonadotropin secretion, but
at mid-cycle, switches to have a potent stimulatory or
‘‘positive feedback’’ action to evoke the luteinizing hor-
mone (LH) surge that triggers ovulation. Although feed-
back effects of estrogen are known to occur at the pitu-
itary gland (Shupnik, 1996), actions of estrogen within
the brain are accepted as being critical for the generation
of the GnRH surge that drives the preovulatory LH surge
in all mammals, including primates (Karsch et al., 1997;
Herbison, 1998).
Even though estrogen positive feedback is central to
mammalian fertility, the underlying mechanism remains
poorly understood. Since GnRH neurons express ERb,
but not ERa, it is possible that estrogen acts directly
upon them to generate the GnRH surge (Herbison and
Pape, 2001; Petersen et al., 2003). However, several
lines of evidence indicate that effects of estrogens
may be transmitted to GnRH neurons in an indirect
manner by ERa- and/or ERb-expressing neurons, glia,
or endothelial cells (Rage et al., 1997; Smith and Jennes,
2001; Prevot, 2002; Petersen et al., 2003). The detailed
investigation of this mechanism has been hampered
by the scattered distribution of the GnRH neurons,
which makes them difficult to investigate technically.
Thus, at present, neither the estrogen receptor subtype
(ERa versus ERb), nor the critical cell types involved in
estrogen positive feedback, have been defined, and
much controversy surrounds this critical issue. A ge-
netic approach to define which of these two estradiol
receptors is crucial for GnRH neuronal activation to in-
duce ovulation, and to characterize its role in specific
cells, might provide valuable insights. Using mice in
which ERa or ERb has been inactivated, we firstly dem-
onstrate here that ERa, but not ERb, is required for
estrogen positive feedback to GnRH neurons. Using
an ERa-selective ligand in wild-type mice, we show
that ERa is not only necessary, but also sufficient to
generate estrogen positive feedback. Secondly, by ex-
ploiting a neuron-specific mutation of the ERa gene,
we were able to identify neurons, as opposed to other
cell types, as critical targets for estradiol action. This
clearly establishes that neurons expressing ERa are re-
quired for estrogen to activate GnRH neurons. Finally,
through use of a GnRH neuron-specific Pseudorabies
virus (PRV) tracing approach, we have been able to de-
fine the location of ERa-expressing neurons projecting
Neuron
272Figure 1. Absence of Estrogen Positive
Feedback in ERa Mutant Mice
(A) Profile of the LH surge in wild-type ovari-
ectomized mice treated with estrogen. n =
4–5 at each time point. Black bar represents
lights out.
(B) Mean (+SEM) LH levels in wild-type-litter-
mates (n = 7) and ERa mutant mice (n = 8)
ovariectomized, treated with estrogen, and
killed at 19:00 hr. *p < 0.05.
(C–E) Dual-label c-Fos (black nuclei) and
GnRH (brown cytoplasmic staining) immuno-
cytochemistry in wild-type (C) and ERa mu-
tant (D) mice. Whereas approximately 40%
of GnRH neurons in wild-type mice express
c-Fos ([C], arrowheads, and [E]), no GnRH
neurons express c-Fos in ERa mutant mice
(D). (F–H) Low-power photomicrographs
showing the location of many c-Fos-express-
ing cells within the AVPV of wild-type mice (F)
compared with few in ERa mutant mice (G).
The mean (+SEM) number of c-Fos cells per
unit area in the AVPV is shown in (H). *p <
0.05. Scale bars represent 30 mm in (C) and
100 mm in (F).to GnRH neurons. These data demonstrate a key role
for ERa in mammalian estrogen positive feedback and
provide definitive evidence for the ‘‘indirect model’’
of estrogen action, in which estrogen regulates ERa-
expressing neuronal afferents to the GnRH neurons
to bring about the preovulatory GnRH/LH surge.
Results
Estrogen Positive Feedback Affecting LH Secretion
and GnRH Neuron Activation Is Absent in ERa
Mutant, but Normal in ERb Mutant, Female Mice
The stimulatory effects of estrogen positive feedback
were evaluated using a protocol that enabled the activa-
tion status of GnRH neurons to be assessed alongside
changes in plasma LH levels. Ovariectomized wild-type
C57BL6/J mice, given an estradiol capsule followed by
an injection of estradiol benzoate, were found to exhibit
an LH surge centered around 19:00 hr, on lights out (Fig-
ure 1A). In the ERamutant mice, there was no evidence of
an LH surge in any of the mice (n = 8) in response to the
same estrogen regimen, with mean LH levels at 19:00 hr
of 1.6 6 0.3 ng/ml compared with 5.2 6 1.0 ng/ml in
wild-type control animals (n = 7, p < 0.05; Figure 1B). In
contrast, clear evidence of an LH surge was observed
in each of the ovariectomized, estrogen-treated ERb
mutant mice (mean LH levels of 8.6 6 1.7 ng/ml com-pared with 8.9 6 1.5 ng/ml in controls, n = 7 for each
group) (Figure 2A).
Approximately 40% of the GnRH neuronal population
expresses the immediate early gene c-Fos at the time of
the GnRH surge, and this is believed to be an accurate
indicator of those GnRH neurons activated by estrogen
to generate the GnRH surge (Hoffman et al., 1993). In ad-
dition, there is increasing evidence that neurons within
Figure 2. Positive Feedback Actions of Estrogen Appear Normal in
ERb Mutant Mice
(A) Mean (+SEM) LH levels in wild-type-littermates (n = 7) and ERb
mutant mice (n = 7) ovariectomized, treated with estrogen, and killed
at 19:00 hr.
(B) The percentage of GnRH neurons (+SEM) found to express c-Fos
in wild-type-littermates (n = 7) and ERb mutant mice (n = 8) ovariec-
tomized, treated with estrogen, and killed at 19:00 hr.
(C) The number of c-Fos-expressing neurons detected within the
AVPV of wild-type-littermates (n = 7) and ERb mutant mice (n = 8)
ovariectomized, treated with estrogen, and killed at 19:00 hr.
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273the anteroventral periventricular nucleus (AVPV) of the
rostral hypothalamus may be an important target for
estrogen in bringing about the GnRH surge (Herbison,
1998; Simerly, 2002). Dual-label immunocytochemistry
(Figures 1C and 1D) revealed that approximately 40%
of GnRH neurons in wild-type mice expressed c-Fos at
the time of the estrogen-induced LH surge (Figures 1C
and 1E). The GnRH neurons expressing c-Fos were lo-
cated preferentially within the preoptic area, with dual-
labeled GnRH neurons only rarely detected in more ros-
tral areas, such as the medial septum (data not shown).
In contrast, we detected no GnRH neurons that ex-
pressed c-Fos in any brain region of ERa mutant mice
(Figures 1D and 1E). The distribution and number of
GnRH neurons detected in wild-type and ERamutant fe-
males were not different (data not shown). In addition,
we found that the numbers of singly-labeled, c-Fos-ex-
pressing cells located within the AVPV were significantly
greater in wild-type mice (Figure 1F) compared with ERa
mutant females (p < 0.05; Figures 1G and 1H).
Single- and dual-label immunocytochemistry experi-
ments in ERb mutant females revealed no differences
in the number of dual-labeled c-Fos-GnRH neurons
compared with wild-type controls (Figure 2B) or in the
number of c-Fos-expressing cells detected in the AVPV
(Figure 2C). The distribution and number of GnRH neu-
rons in wild-type and ERb mutant females were also
not different (data not shown).
An ERa-Specific Ligand Is Sufficient to Generate
Positive Feedback in Wild-Type Mice
The results with the ERa and ERb mutant mice indicated
that ERa was necessary for estrogen positive feedback.
To evaluate whether ERa pathways were sufficient for
positive feedback, wild-type mice were given the ERa-
selective compound 16a-LE2 [3,17-dihydroxy-19-nor-
17a-pregna-1,3,5 (10)-triene-21,16a-lactone] (Hegele-
Hartung et al., 2004) as the second estradiol injection
alongside control mice receiving the normal, previously
outlined estrogen protocol. The second estradiol injec-
tion is critical for evoking positive feedback, as mice
given vehicle control at this time point never exhibit an
LH surge. Mice treated with 16a-LE2 (n = 5) exhibited
an LH surge at 19:00 hr (LH, 5.9 6 1.7 ng/ml, compared
with normal estrogen-treated controls, 6.5 6 2.3 ng/ml)
and had 49% 6 7% of rostral preoptic area GnRH neu-
rons expressing c-Fos (compared with controls that
had 60% 6 11%).
Together, these observations demonstrate that cells
expressing ERa are both necessary and sufficient for
estrogen positive feedback actions upon GnRH neu-
rons. As GnRH neurons do not express ERa, these re-
sults demonstrate that ERa-expressing neuronal, glial,
or other cell types must mediate estrogen positive feed-
back actions upon GnRH neurons.
Neuron-Specific ERa Mutant Mice Are Infertile
To examine the hypothesis that estrogen acts through
ERa-expressing neurons, rather than other cell types,
to activate GnRH neurons, neuron-specific ERa mutant
mice were developed by breeding ERaflox mice with a
CamKIIa-Cre transgenic mouse line. Immunocytochem-
ical analyses of ERa expression in the resulting mice
showed that ERa immunoreactivity was absent fromthe hypothalamus (Figures 3A and 3B) and all other brain
regions (see Figure S2 in the Supplemental Data) of
ERafl/fl;CamKIIa-Cre mice. In contrast, ERa protein
was detected in the pituitary of all genotypes, including
female ERafl/fl;CamKIIa-Cre mice (Figures 3A and 3B,
insets). Female ERafl/fl;CamKIIa-Cre mice were found
to be infertile and, from an age of 5 to 6 weeks, to exhibit
striking abnormalities in their reproductive organs (Fig-
ure 4). In the mutants, the uterus was grossly enlarged
and filled with liquid (Figure 4B). The endometrium, how-
ever, was severely atrophic and lacked all glandular
structures. Whereas the endometrial stroma was loose
and vascularized in control mice (Figure 4C), it appeared
condensed and showed granulocyte infiltration in the
mutants (Figure 4D). Histologically, the ovaries of
ERafl/fl;CamKIIa-Cre mice showed signs of gonadotro-
pin hyperactivation; in mutant mice, ovaries contained
a large number of antral follicles compared with wild-
type animals (Figures 4E and 4F). In the ovarian hilus,
theca cells appeared hypertrophic and luteinized in mu-
tant animals, indicating inappropriate stimulation of the
ovaries. Furthermore, no corpora lutea were observed in
the ovaries of mutants (Figure 4F), suggesting a failure of
ovulation. Basal LH levels were not different between
diestrous controls (0.91 6 0.11 ng/ml) and ERafl/fl;Cam-
KIIa-Cre (1.23 6 0.08 ng/ml) female mice.
Figure 3. Absence of Estrogen Positive Feedback in Neuron-
Specific ERa Mutant Mice
(A and B) ERa expression in the rostral hypothalamus within the an-
teroventral periventricular nucleus (AVPV) of (A) control ERafl/fl and
(B) neuron-specific ERa mutant ERafl/fl;CamKIIa-Cre mice. Scale
bar, 100 mm, 3V = third ventricle, OC = optic chiasm. (Insets) Equiv-
alent ERa staining in the anterior pituitary of (A) control and (B) neu-
ron-specific ERa mutant mice.
(C) Mean (+SEM) LH levels in control littermates (n = 5) and ERafl/fl;
CamKIIa-Cre mice (n = 4) ovariectomized, treated with estrogen,
and killed at 19:00 hr. * p < 0.05.
(D) Approximately 40% of GnRH neurons express c-Fos in control
mice ovariectomized, treated with estrogen, and killed at 19:00 hr,
whereas none are found in ERafl/fl;CamKIIa-Cre mice.
(E) The number of c-Fos-expressing neurons detected within the
AVPV of controls and ERafl/fl;CamKIIa-Cre mice ovariectomized,
treated with estrogen, and killed at 19:00 hr. *p < 0.05.
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Generate Estrogen Positive Feedback
Ovariectomized, estrogen-treated ERafl/fl;CamKIIa-Cre
mice (n = 6) failed to exhibit an LH surge, with mean
LH levels of 0.9 6 0.2 ng/ml at 19:00 hr compared with
5.8 6 2.1 ng/ml in littermate controls (n = 5; Figure 3C).
Immunocytochemical experiments did not detect c-Fos
in any GnRH neurons in ERafl/fl;CamKIIa-Cre mice fol-
lowing estrogen treatment. This compared with c-Fos
in 41% 6 8% of GnRH neurons in littermate controls
(Figure 3D).
As c-Fos protein is detectable for 5–6 hr in GnRH neu-
rons following the GnRH/LH surge (Lee et al., 1990), we
additionally evaluated c-Fos expression in GnRH neu-
rons at midday of the expected day of the surge and
at 01:00 hr (1 a.m.) on the following day to evaluate
whether the timing of positive feedback had been al-
tered in ERafl/fl;CamKIIa-Cre mice. We found a complete
absence of c-Fos in GnRH neurons at these time points.
As we find no evidence for c-Fos in GnRH neurons of
ERafl/fl;CamKIIa-Cre mice at 13:00 hr, 19:00 hr, or
01:00 hr the next day, it seems unlikely that the GnRH
neurons receive either an early or delayed positive feed-
back signal in ERafl/fl;CamKIIa-Cre mice.
The distribution and number of GnRH neurons in
ERafl/fl;CamKIIa-Cre brains was identical to that of con-
trols (data not shown). Whereas numbers of c-Fos-pos-
itive cells in a control brain region were not different
between control littermates (5.1 6 2.2 cells/unit area/
section) and ERafl/fl;CamKIIa-Cre mice (8.3 6 1.6 cells/
unit area/section), significantly more singly-labeled c-Fos
cells were detected within the AVPV of littermate controls
Figure 4. Ovarian and Uterine Phenotype of Neuron-Specific ERa
Mutant Mice
(A and B) Reproductive tract of control ERafl/fl (A) and mutant ERafl/fl;
CamKIIa-Cre (B) mice showing fluid-filled uteri in mutants.
(C and D) H&E staining of uteri from control ERafl/fl (C) and mutant.
ERafl/fl;CamKIIa-Cre (D) mice shows atrophy and lack of glandular
structures in the mutant.
(E and F) H&E staining of ovaries from control ERafl/fl (E) and mutant
ERafl/fl;CamKIIa-Cre (F) mice shows increased numbers of antral
follicles and lack of corpora lutea in the mutant.compared with ERafl/fl;CamKIIa-Cre mice (p < 0.05; Fig-
ure 3E). These data closely resemble that of the global
ERamutant mouse and indicate that ERa-expressing neu-
rons are critical for estrogen positive feedback to occur.
The ERa-Expressing Primary Afferents to GnRH
Neurons Are Located within Periventricular Regions
of the Rostral Hypothalamus
The studies above show that ERa-expressing neurons
are critical for estrogen positive feedback to GnRH neu-
rons. To identify the locations of these cells within the
GnRH neuronal network, we have used a Cre-dependent
PRV retrograde tracing strategy in GnRH-Cre mice (De-
Falco et al., 2001; Yoon et al., 2005). In this approach, the
Ba2001 PRV is activated only after infecting a Cre-
expressing GnRH neuron in vivo. This allows for the now
unconditional PRV to replicate and to pass in a retro-
grade manner to the primary afferents of the GnRH neu-
ron and, subsequently, their own afferents in a time-
dependent manner. The retrograde chain of infection can
be followed by evaluating GFP expression as the uncondi-
tional Ba2001 PRV also expresses GFP ineach cell it infects.
Five founder GnRH-Cre lines were generated. Analy-
sis of Cre expression by dual-label immunocytochem-
istry in adult female mice revealed that one of these
lines expressed Cre in a highly selective manner within
97% 6 2% of all GnRH neurons (n = 6; Figure 5A).
Crossing this line with the ROSA-26 indicator mice
(Soriano, 1999) revealed Cre-dependent recombination
in 97% 6 1% of GnRH neurons (n = 4; not shown).
To evaluate the ERa-expressing afferents to the GnRH
neuron population that is activated at the time of the
GnRH surge (i.e., those in the rostral preoptic area), a sin-
gle 500 nl injection of Ba2001 PRV was given into the ros-
tral preoptic area of adult female mice. Mice examined
at 6, 12, 24, and 30 hr after injection of Ba2001 (n = 8) dis-
played no evidence of GFP expression in any region of
the brain. However, 48 hr after PRV injection (n = 4), we
found that between five and nine GnRH neurons located
around the injection site expressed GFP (Figures 5B and
5C) indicating that Cre-mediated recombination had
occurred in these cells. No other GFP-expressing cells
were detected within the brain at this time point. Sev-
enty-two hours following PRV injection, GFP-expressing
cells (representing afferent neurons to rostral preoptic
GnRH neurons, Figure 5D) were identified in multiple
brain regions. Twenty-four hours later (96 hr post-injec-
tion), we found a much larger distribution and number
of GFP-expressing cells. As 24 hr is required for PRV to
move from one order of neurons to the next (Card and
Enquist, 1995; Horvath et al., 2002), the neurons identi-
fied at 72 hr post-injection are almost certainly primary
afferents to GnRH neurons.
At 72 hr post-injection (n = 6), GFP-expressing neurons
were identified in multiple areas of the forebrain and
brainstem (Figure 5G). The regions displaying the largest
numbers of retrogradely labeled neurons were the hypo-
thalamic periventricular nucleus (PeN; mean of 36 cells/
mouse in a 1:3 series of brain sections), AVPV (23 cells),
median preoptic nucleus (MnPO; 14 cells), and dorsal
raphe (16 cells). Other brain regions that consistently ex-
hibited GFP-expressing neurons at lower densities were
the lateral septum, arcuate nucleus (ARN), and nucleus
tractus solitarius (Figure 5G).
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275Figure 5. Identification of ERa-Expressing Primary Afferents to GnRH Neurons Using GnRH Neuron-Specific Viral Mediated Tracing
(A) Restricted expression of Cre (black nuclei) in GnRH neurons (brown cytoplasm) of transgenic GnRH-Cre mice. (B and C) A rostral preoptic
area GnRH neuron adjacent to the injection site (arrowheads) exhibiting GFP immunoreactivity 48 hr following injection of Ba2001. (B) shows GFP
immunoreactivity and (C) is GnRH immunostaining. (D) Four neurons (arrows) in the AVPV exhibiting GFP immunoreactivity 72 hr after Ba2001
injection into the rostral preoptic area. (E) Dual labeling for GFP (green) and ERa (red) reveals that two of these cells (arrows) express ERa. (F)
Schematic brain maps demonstrating GFP-immunoreactive neurons (open stars) and GFP+ERa immunoreactive (filled stars) cells detected
in individual 30 mm-thick coronal brain sections at three levels in the hypothalamus. Abbreviations: aca, anterior commisure; ARN, arcuate
nucleus; AVPV, anteroventral periventricular nucleus; f, fornix; MnPO, median preoptic nucleus; ME, median eminence, PeN, periventricular
nucleus; 3V, third ventricle. Scale bar, 15 mm in (A), (C), and (D).
(G) Summary of locations of primary afferents to GnRH neurons following stereotaxic injection of Ba2001 PRV into the rostral preoptic area
(rPOA) of GnRH-Cre mice. Various colors in boxes adjacent to listed brain areas indicate ranges of mean numbers of GFP-positive neurons iden-
tified in female mice (n = 6). Brain regions in which labeled cells were detected in <5 of the six mice are indicated as yellow boxes (variable). Right-
most column indicates the mean percentage (6SEM) of GFP-positive neurons expressing ERa immunoreactivity. Abbreviations: ARN, arcuate
nucleus; AVPV, anteroventral periventricular nucleus; DBB, diagonal band of Broca; DMH, dorsomedial hypothalamus; DR, dorsal raphe; LC,
locus coereulus; LH, lateral hypothalamus; LS, lateral septum; MnPO, median preoptic nucleus; MPN, medial preoptic nucleus; MS, medial
septum; NTS, nucleus tractus solitarius; PAG, periaqueductal gray; PeN, periventricular nucleus; PVN, paraventricular nucleus; SFO, subfornical
organ; VMN, ventromedial nucleus.Dual-label immunocytochemistry (n = 6) for GFP and
ERa (Figures 5D and 5E) identified ERa-expressing
afferents as being located in four brain regions: the
AVPV, MnPO, PeN, and ARN (Figure 5F). The percentage
of GFP-positive neurons expressing ERa was 53% 6
12%, 34% 6 21%, and 24% 6 11% in the AVPV,
MnPO, and PeN, respectively, and 56% 6 19% for the
ARN, although we only ever observed 1–2 GFP-
expressing cells in the ARN (Figure 5G). To ensure the
neuronal identity of PRV-infected cells expressing
ERa, immunocytochemical labeling for GFP and ERa
was undertaken in combination with Nissl staining. All
GFP/ERa-expressing cells were also positive for Nissl
(Figure S3). Injections of Ba2001 PRV into the rostral
preoptic area of wild-type, non-Cre-expressing mice,
or into the striatum of GnRH-Cre mice, resulted in a com-
plete absence of GFP-expressing neurons. These
findings demonstrate that ERa-expressing primary af-
ferents to GnRH neurons have their cell bodies located
principally within rostral periventricular nuclei of the
hypothalamus.The findings of the PRV study demonstrated that
significant estrogen-receptive primary afferents to the
GnRH neurons existed in the PeN and MnPO in addition
to the AVPV. As such, we returned to the estrogen
positive feedback c-Fos studies and examined c-Fos
expression in the MnPO and PeN of ERa and ERbmutant
mice. The numbers of c-Fos cells in the PeN of mice
treated with estrogen were significantly reduced in
ERa mutants (22 6 3 cells, p < 0.05) compared with
wild-type mice (40 6 6 cells per section), but were
unchanged in ERb mutant females. The numbers of
c-Fos-expressing cells in the MnPO were not significantly
different in either ERa or ERb mutant mice compared
with controls. These data indicate that a subpopulation
of cells within the PeN, as well as the AVPV, is activated
by estrogen positive feedback.
Discussion
We have used here a series of ER mutant mouse models
and an ER-selective ligand to demonstrate the critical
Neuron
276receptor isoform and cell type necessary and sufficient
for estrogen to initiate the GnRH/LH surge and ovula-
tion. We show that global ERb mutant mice exhibit
normal patterns of estrogen-induced GnRH activation
and LH surge secretion. In contrast, global ERa mutant
mice fail to exhibit GnRH neuron activation or LH surge
secretion in response to estrogen. As GnRH neurons
do not express ERa (Herbison and Pape, 2001), this
indicated that positive feedback effects of estrogen
must occur in an indirect manner. To define the critical
ERa-expressing cell-type in the pathway, neuron-
specific ERa mutant mice were generated by crossing
a floxed exon 3 ERa mouse line with CamKIIa-Cre
mice. CamKIIa is expressed selectively by forebrain neu-
rons (Ouimet et al., 1984; Burgin et al., 1990) and the
CamKIIa-Cre mouse line used here has been shown
previously to efficiently delete loxP-flanked target se-
quences in neurons of the CNS, leading to neuron-
specific gene ablation (Casanova et al., 2001; Marsicano
et al., 2003). Mice harboring a neuron-specific ERa dele-
tion were found to be infertile and lack estrogen positive
feedback, demonstrating that ERa-expressing neurons
are critical. To define the location of these neurons, we
have used a Cre-dependent PRV retrograde tracing
strategy to demonstrate that the ERa-expressing pri-
mary afferents to GnRH neurons are located primarily
within the periventricular nuclei of the rostral hypothala-
mus. Together, these observations provide conclusive
evidence that critical positive feedback actions of
estrogen upon GnRH neurons are mediated by ERa-
expressing neuronal afferents within the GnRH neuronal
network.
It is now recognized that estrogen can modulate the
activity of neuronal networks through multiple mecha-
nisms including both slow genomic and rapid actions
(McEwen and Alves, 1999). In the case of estrogen pos-
itive feedback, however, it seems clear that classical
genomic mechanisms underlie the estrogen activation
of GnRH neurons. In all species examined, positive feed-
back only occurs after several hours of estrogen expo-
sure (Legan et al., 1975; Bronson, 1981; Xia et al.,
1992; Evans et al., 1997). Furthermore, once the animal
has been exposed to estrogen for a sufficient period,
estrogen can be removed without having any negative
effect upon subsequent GnRH neuron activation. Thus,
rapid and immediate actions of estrogen are not likely
to be critical for GnRH neuron activation, and positive
feedback relies upon a classical genomic mechanism.
The downstream genes regulated by estrogen to bring
about GnRH neuron activation are not yet established,
although the progesterone receptor is one candidate
known to be potently regulated by estrogen (Levine,
1997; Shughrue et al., 1997). The finding of ERb mRNA
and protein in GnRH neurons of the mouse (Skynner
et al., 1999a), the rat (Hrabovszky et al., 2001), and
more recently, the sheep (Skinner and Dufourny, 2005)
raised the possibility that estrogen might act directly
upon GnRH neurons via this isoform to generate the
GnRH/LH surge (Herbison and Pape, 2001). However,
in terms of both LH secretion and immediate early
gene expression in GnRH neurons, we found that
estrogen positive feedback is normal in the global
ERb mutant mouse. This strongly suggests that ERb-
regulated signaling within GnRH neurons is not criticalfor estrogen’s positive feedback effects upon these
cells.
The global ERamutant mice are infertile and exhibit an
anovulatory ovarian phenotype with polycystic follicles
and an absence of corpora lutea (Couse et al., 1999;
Couse and Korach, 1999). We provide evidence here
that the failure of estrogen positive feedback on the
GnRH neuronal network is very likely to underlie the
anovulatory phenotype of the global ERa mutant mice.
Estrogen administration to ovariectomized global ERa
mutant mice failed to generate an LH surge or evidence
of GnRH neuron activation. This provided direct evi-
dence of the critical importance of ERa-expressing cells
in positive feedback. In keeping with this observation,
the ERa-selective compound 16a-LE2 (Hegele-Hartung
et al., 2004) was found to be capable of eliciting normal
positive feedback in wild-type mice. This indicates that
ERa activation is both necessary and sufficient for pos-
itive feedback to occur, and that estrogen acts indirectly
to activate GnRH neurons. Several different modes of in-
direct estrogen input to the GnRH neurons have been
proposed and include effects mediated by vascular en-
dothelial cells, tanycytes, glial cells, and interneurons
(Rage et al., 1997; Herbison, 1998; Smith and Jennes,
2001; Prevot, 2002; Petersen et al., 2003). Using a Cre-
LoxP conditional mutagenesis strategy to generate a
neuron-specific ERa knockout, we have been able to
demonstrate that, of these possibilities, it is ERa-ex-
pressing neurons within the network that are critical
for estrogen positive feedback. Other cell types ex-
pressing ERa may play a role in positive feedback, but
are insufficient by themselves to activate the GnRH neu-
rons to generate the GnRH/LH surge. Thus, the present
genetic dissection of the estrogen positive feedback
mechanism identifies clearly both the critical ER isoform
and cell type involved.
The absence of estrogen positive feedback in neuron-
specific ERa mutant mice is entirely compatible with
their infertile reproductive phenotype. Ovarian histology
shows an absence of corpora lutea and an abundance of
antral follicles, supporting the failure of the ovulatory
mechanism. In contrast to the global ERa mutant line,
there was no evidence in neuron-specific ERa mutant
mice for a polycystic hemorrhagic ovarian phenotype
generated by excessive gonadotrophin secretion (Couse
et al., 1999). Indeed, basal LH levels are not elevated in
neuron-specific ERa mutant mice, suggesting that pitu-
itary estrogen negative feedback is probably sufficient
to restrain gonadotrophin secretion. Another prominent
feature of the neuron-specific ERa mutant mice is that
of dilated, fluid-filled uteri, reminiscent of those found
at proestrus. Unlike in the global ERa mutant mouse
(Couse and Korach, 1999; Dupont et al., 2000), the uteri
of neuron-specific ERa mutant mice remain sensitive to
estrogen and may be exposed to a continual high level
of estrogen originating from the large numbers of devel-
oping follicles. Thus, the reproductive phenotype of the
neuron-specific ERa mutant mouse is compatible with
that of a mouse in which estrogen negative feedback
is competent, but positive feedback is absent. This
would enable relatively normal basal gonadotrophin
secretion, sufficient to promote follicular growth and
estrogen production, to exist in association with a com-
plete failure of ovulation.
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trogen-sensitive brain region involved in the positive
feedback mechanism (Wiegand and Terasawa, 1982;
Herbison, 1998; Simerly, 2002). The present results
provide definitive evidence for this hypothesis and also
suggest that the locations of estrogen-sensitive neurons
involved in estrogen positive feedback include the pre-
optic PeN immediately caudal to the AVPV. To determine
the locations of ERa-expressing afferents to GnRH
neurons, we generated a GnRH-Cre transgenic mouse
for use with a Cre-dependent PRV retrograde tracing
strategy (DeFalco et al., 2001). By establishing a time
course of viral infection and restricting our PRV injection
sites to the rostral preoptic area, where GnRH neurons
expressing c-Fos at the time of positive feedback
reside, we traced out the primary afferents to the sub-
population of GnRH neurons activated by estrogen to
create the preovulatory GnRH surge. Primary afferent
inputs to GnRH neurons were found to originate from
a variety of predominantly midline hypothalamic and
brainstem locations. However, the subpopulations of
ERa-expressing afferents were found to be tightly clus-
tered within the rostral preoptic area. In addition to
a strong projection from ERa-expressing neurons in
the AVPV, we also identified populations of ERa primary
afferents originating from the PeN and, nearby the GnRH
somata, in the MnPO. Our c-Fos studies support the
functional relevance of both AVPV and PeN neurons in
estrogen positive feedback, since a strong correlation
existed between levels of c-Fos in these brain regions
and GnRH neuron activation and the occurrence of an
LH surge. A similar observation has been made in
the rat, where c-Fos is expressed by AVPV/PeN neurons
in response to estrogen positive feedback (Le et al.,
1999).
Brought together, the evidence for the AVPV and PeN
as sites of primary afferents mediating estrogen positive
feedback to rodent GnRH neurons is now very strong; (1)
lesions of the AVPV/ventral PeN abolish positive feed-
back (Wiegand and Terasawa, 1982), (2) implantation
of anti-estrogens in the AVPV/PeN abolish positive feed-
back (Petersen and Barraclough, 1989), (3) AVPV and
PeN neurons provide inputs to GnRH neurons (present
study; Horvath et al., 1993; Gu and Simerly, 1997; Simo-
nian et al., 1999), (4) neurons expressing ERa are critical
for estrogen positive feedback (present study), (5) AVPV
and PeN neurons express ERa and are activated by es-
trogen positive feedback (present study; Le et al., 1999),
and (6) AVPV/PeN neurons expressing ERa project
directly to GnRH neurons (present study).
Together, these studies clarify the mechanism of
estrogen positive feedback to GnRH neurons by pro-
viding definitive evidence that it is ERa, and not ERb,
that is critical and that the neuron-specific ablation of
ERa renders mice infertile with a complete ablation of
estrogen positive feedback. Thus, estrogen acts indi-
rectly upon GnRH neurons to bring about positive
feedback driving ovulation, and the ERa-expressing
neurons mediating this pathway are located in periven-
tricular regions. Future studies involving the genetic
ablation of ERa in specific neuronal phenotypes will
now be required to define the hierarchy of periven-
tricular neurons mediating estrogen feedback to GnRH
neurons.Experimental Procedures
Generation of an ERaflox Mouse Line
A conditional allele of the mouse Esr1 allele was generated. The tar-
geting construct (pERaflox.tkneo.DTA) (Figure S1A, top panel) was
based on a 9 kb BamHI fragment representing the genomic se-
quence of exon 3 and surrounding introns of the mouse Esr1 gene
(Figure S1A, second panel). This fragment, obtained from the
RPCI21 mouse genomic library (Vente et al., 1999), was modified us-
ing homologous recombination in E. Coli (Zhang et al., 1998) to carry
a loxP site 50 to exon 3, a PGKtkneo cassette flanked by frt sites, and
one loxP site in the 30 direction of exon 3. E14 embryonic stem cells
were transfected with the linearized targeting construct and se-
lected for construct integration (Tronche et al., 1999). G418-resistant
clones were characterized by Southern blot using external genomic
probes from the Estra locus (Figure S1B). Clones that had under-
gone homologous recombination were transiently transfected
with the expression plasmid pCAGGS-Flpe (Schaft et al., 2001)
and selected with 1 mM Gancyclovir to isolate subclones that
have lost the selection cassette after Flp recombination. This was
verified by Southern blot analysis (Figure S1C). From the resulting
embryonic stem cell clones, chimeric mice were generated by
blastocyst injection and uterine transfer. By breeding these chi-
meras to C57BL/6 mice, the ERaflox mouse line was established.
To generate a neuron-specific ERa knockout mouse, ERaflox mice
were bred to CamKIIa-iCre BAC transgenic mice (referred to as
CamKIIa-Cre mice) (Casanova et al., 2001). CamKIIa is expressed
around birth in almost all forebrain neurons but not in glial cells (Oui-
met et al., 1984; Burgin et al., 1990). This resulted in the generation of
ERafl/fl;CamKIIa-Cre mice with both heterozygous ERa+/fl;CamKIIa-
Cre mice and ERafl/fl mice serving as controls.
Generation of a GnRH-Cre Transgenic Mouse
The GnRH-Cre mouse was generated in the same manner as re-
ported previously (Skynner et al., 1999b) using anw12 kb transgene
incorporating all the introns and exons of the GnRH gene, 5.5 kb of
upstream (50) and 3.5 kb of downstream (30) flanking sequence, and
a SmaI site engineered by site-directed mutagenesis in exon II be-
tween sequences encoding amino acids 2 and 3 of the GnRH decap-
eptide. An expression cassette consisting of (in 50 to 30 order) a syn-
thetic intron, nuclear-localizing signal, CRE recombinase, and a
polyadenylation (polyA) sequence was then inserted at the SmaI
site to produce the transgene. Transgenic mice were produced by
pronuclear injection and identified by PCR analysis of genomic
DNA isolated from tail biopsies.
Animals and Estradiol-Induced LH Surge Protocol
All animal experimental procedures were approved by the University
of Otago Animal Ethics Committee and the Regierungspra¨sidium
Karlsruhe. Animals were housed in groups of three to four per
cage with food and water freely available and a 12:12 lighting sched-
ule (lights on 07:00 hr, off 19:00 hr). Genotyping of ERa mutant and
ERbmutant mice was undertaken as described previously (Abraham
et al., 2003). Adult (>60 days of age) wild-type and ER mutant female
C57BL6/J mice were anesthetized with Halothane, ovariectomized,
and implanted subcutaneously with an estradiol-filled Silastic
capsule. Estradiol capsules were made according to the protocol
of Bronson (Bronson, 1981), and involved filling Silastic tubing
(1.0 mm internal, 2.1 mm external diameter; Dow Corning, MI) with
Silastic medical-grade adhesive (Dow Corning) containing 17-b-
estradiol at a concentration of 0.1 mg/ml adhesive. Each mouse was
given an w1 cm length of Silastic tubing (1 mg estradiol/20 g body
weight). To prevent infection in brain-specific ERa knockout mice
(see below), ERafl/fl;CamKIIa-Cre mice and controls were given daily
s.c. injections of 5 ml/g Baytril 0.1% (Bayer, Leverkusen, Germany)
for 5 consecutive days, starting 2 days pre-ovariectomy (OVX). Six
days after OVX, mice received a subcutaneous injection of estradiol
benzoate (1 mg/20g body weight, Intervet, Castle Hill, Australia) at
09:00 hr. On the following day, animals were killed with an i.p. over-
dose of pentobarbitone, and trunk blood was collected between
17:00 and 21:00 hr for LH radioimmunoassay. The sensitivity of the
radioimmunoassay was 0.4 ng/ml and had an intra-assay coefficient
of variation of 12.1%.
Neuron
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wild-type mice were treated as above and groups of 4–5 mice were
killed at 17:00 hr, 18:00 hr, 19:00 hr, 20:00 hr, and 21:00 hr to ascer-
tain the profile of the LH surge. As this showed that 19:00 hr repre-
sented the time of peak LH secretion, further experiments were un-
dertaken by killing mice at 19:00 hr. In the second experiment, ERa
mutant and wild-type littermates (n = 7–8 each group) were treated
as above and anesthetized with pentobarbitone. A 0.3 ml blood sam-
ple was obtained from the right atrium before perfusion of the mouse
through the left ventricle with 15 ml 4% paraformaldehyde fixative
solution. Brains were then removed and postfixed for 90 min at
room temperature in 4% paraformaldehyde before being placed in
a 30% sucrose/Tris-buffered saline (TBS) solution overnight. The
third experiment involved the same procedure, only using ERb mu-
tant mice and wild-type littermates (n = 7 each group). The fourth
experiment used wild-type adult female mice given the estrogen-
replacement protocol, only with half of the mice receiving the ERa-
selective agonist 16a-LE2 (0.8 mg/20 g body weight, s.c.; kind gift
of Schering AG, Berlin, Germany) instead of the estradiol benzoate
injection. At this dose, 16a-LE2 is highly selective for ERa in vivo
(Hegele-Hartung et al., 2004). The fifth experiment involved neuron-
specific ERa knockout mice (n = 4; ERafl/fl;CamKIIa-Cre genotype)
and control littermates (n = 4–5; ERa+/fl;CamKIIa-Cre, ERafl/fl, and
ERa+/fl genotypes) treated as above. To evaluate possible altered
timing of positive feedback and the LH surge in these mice, animals
were perfused at 13:00 hr, 19:00 hr, and 01:00 hr with pituitaries
additionally collected alongside the brains. In each experiment, indi-
vidual control and ER mutant mice were perfused in an alternate
manner.
Immunohistochemistry
Single-label ERa immunohistochemistry was performed using either
the monoclonal rat H222 antibody (1.3 mg/ml, gift of Abbott Labora-
tories, IL) for free-floating brain sections or a polyclonal rabbit anti-
body (1 mg/ml, MC-20, SC-542, Santa Cruz Biotechnology, CA) for
the pituitary. Brain sections were cut in the coronal plane at 30 mm
on a freezing microtome and processed as free-floating sections
using biotinylated anti-rat IgGs followed by the VECTASTAIN ABC
system (Vector Laboratories) with nickel-diaminobenzidine as the
chromagen. Fixed pituitaries were dehydrated, embedded in paraf-
fin wax, and cut into 6 mm sections for slide-mounted immunohisto-
chemistry using biotinylated anti-rabbit IgGs and the VECTASTAIN
ABC system with diaminobenzidine.
Dual-label c-Fos and GnRH immunocytochemistry was under-
taken as described previously (Herbison et al., 1995). Briefly, the ros-
tral forebrain was cut into three sets of 30 mm-thick coronal sections
and one set was immunostained for c-Fos (Li et al., 1999) using
a polyclonal rabbit anti-c-Fos antibody (1:10,000, SC52, Santa
Cruz Biotechnology Inc., Santa Cruz, CA) followed by biotinylated
anti-rabbit IgGs (1:200; Vector, Burlingame, CA) and Vector Elite av-
idin-peroxidase (1:100) and revealed using nickel-diaminobenze-
dine hydrochloride. A second sequential staining using a rabbit
anti-GnRH antibody (1:40,000; LR1, gift of R. Benoit, Montreal) and
peroxidase-labeled anti-rabbit immunoglobulins (1:400; Vector
Labs) revealed by diaminobenzidine hydrochloride alone was used
to visualize the GnRH neurons. The removal of either primary anti-
bodies resulted in a complete absence of the respective immunore-
activity.
Analysis was undertaken by counting the numbers of single-la-
beled (brown cytoplasm only) and dual-labeled (brown cytoplasm
and black nucleus) GnRH neurons. The distribution and number of
dual-labeled GnRH neurons were counted in the regions of the me-
dial septum, rostral preoptic area, and anterior hypothalamic area,
represented by plates 22–24, 25–27, and 28–31, respectively, of
the Franklin and Paxinos brain atlas (Franklin and Paxinos, 1997).
In addition, the number of c-Fos-labeled cells identified within the
AVPV, PeN, and MePN were counted. Cell counts in the AVPV
were determined by placing a right-angle triangle (160 mm base 3
400 mm side) over the AVPV (plate 29) and counting all immunoreac-
tive nuclei bilaterally on two sections from each mouse. The same
procedure was undertaken for the MnPO by placing a square
(300 mm 3 300 mm) over the midline MnPO (plate 27) and counting
the numbers of c-Fos-immunoreactive cells in 2 sections from
each mouse. Counts in the PeN were undertaken in the same wayby placing a rectangle (60 mm 3 800 mm) next to the third ventricle
and the level of plate 31. Values for each mouse were used to deter-
mine mean counts and these were used to generate means + SEM
values for each group. All data were analyzed by nonparametric
Mann-Whitney U tests with a p < 0.05 considered significant.
Conditional Pseudorabies Virus Tracing
The conditional PRV strain, Ba2001, was generated as described
previously (DeFalco et al., 2001) (3.8 3 108 pfu/ml) and stored at
280C until use. Intracerebral stereotaxic injections of Ba2001
were made in Avertin-anaesthetized adult female GnRH-Cre mice.
A Hamilton syringe was used to deliver 500 nl of Ba2001 into the ros-
tral preoptic area (coordinates: 0.0 mm bregma, 0 mm lateral, 25.1
mm dorsal-ventral) at a rate of 20 nl/min. The needle was left in place
for 5 min following injection. Control injections were made into the
preoptic area of wild-type mice and into the striatum of GnRH-Cre
mice. Mice were killed at various time points after injection and brain
tissue was prepared for immunohistochemical processing as de-
scribed above. Thirty-micrometer-thick sections underwent dual la-
beling for either GFP (to detect PRV infected cells) and GnRH or GFP
and ERa. The following antibodies were used: chicken anti-GFP
(1:2500; Chemicon), rabbit anti-GFP (1:5000, Molecular Probes),
rabbit anti-GnRH antibody (1:40,000; LR1, gift of R. Benoit, Mon-
treal), and rabbit anti-ERa (1:10,000, Upstate). GFP/GnRH dual label-
ing was visualized using anti-rabbit IgGs followed by streptavidin
568 (1:200; Molecular Probes) and anti-chicken FITC (1:200; Jackson
Immunolabs). GFP/ERa dual labeling was visualized with biotiny-
lated anti-rabbit IgGs followed by streptavidin 568 (1:200; Molecular
Probes), and anti-chicken FITC (1:200; Jackson Immunolabs). Every
section throughout the brain of 72 hr post-injection female mice (n =
6) was analyzed for GFP/GnRH dual labeling using an Olympus BX51
epifluorescence microscope. Dual labeling for GFP/ERa was ana-
lyzed in every third section throughout the forebrain (n = 5). GFP/
ERa/Nissl staining was undertaken by including a final incubation
step in Neurotrace 435/455 blue fluorescent Nissl stain (1:100,
Molecular Probes).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/2/271/DC1/.
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